{"id":7885,"date":"2010-02-22T12:00:57","date_gmt":"2010-02-22T12:00:57","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=7885"},"modified":"2013-08-23T12:37:44","modified_gmt":"2013-08-23T12:37:44","slug":"volume-11-number-12-januaryfebruary-2010","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/7885","title":{"rendered":"Volume 11 Number 1\/2 January\/February2010"},"content":{"rendered":"<p>Welcome to the first issue of HTB for 2010 which includes reports from the EACS Conference and updates of three important guidelines.<\/p>\n<p>At EACS, we start with a review that focused on the lack of screening programmes for anal cancer for HIV-positive people. Many studies have already<br \/>\nhighlighted that the increased risks, especially for gay men, are comparable to rates of cervical cancer in women prior to those screening programmes.<br \/>\nFocussing on the benefits of newer treatment options to successfully reverse this disease, the review suggests that there is now compelling evidence<br \/>\nsupporting more active monitoring.<\/p>\n<p>An ongoing UK review due in April 2010 will hopefully reverse the decision made at the previous review (in 2003), though this will also be related to<br \/>\nwhether HIV-positve gay men are seen as a group that deserves further interventions. The study reported later in this issue of HTB, by Bini and<br \/>\ncolleagues, adds to the growing evidence to at least support a UK pilot screening programme in the highest risk groups.<\/p>\n<p>Our coverage of guidelines includes new communications from the US DHHS panel, WHO, and PENTA.<\/p>\n<p>Each document includes valuable guidance for clinical management of HIV-positive patients and is essential reading. However, as the remit for each<br \/>\nguideline ranges between defining a minimum standard of care and a more aspirational summary of best possible care, they also highlight controversial<br \/>\nissues for which evidence is still lacking.<\/p>\n<p>In the US DHHS panel review, the recommendation to universally start treatment at any CD4 count lower than 500 cells\/mm3 is problematic given the<br \/>\nconfounding issues from cohort studies on which the recommendation is based.<\/p>\n<p>As the large randomised START study addressing the risks and benefits of earlier treatment is just enrolling, the decision to guess these results is<br \/>\npremature.<\/p>\n<p>START, and it\u0092s related sub-studies, is likely to provide the most important dataset to inform not only the question of when to start treatment, but also<br \/>\nabout the pathogenesis of essential aspects of HIV, treatment and aging including neurological and bone health. It is welcomed that the WHO guidelines<br \/>\nalso recommend earlier treatment (at CD4 &lt;350) and that they place a stronger emphasis on using alternative nucleosides to d4T. However, arguably<br \/>\nearlier treatment should only be recommended in settings where non-d4T-based regimens are freely accessible, and in this aspect of management is not<br \/>\ndiscussed.<\/p>\n<p>We also include latest reviews of drug interactions from HIV-druginteractions.org and basic science reviews from Richard Jefferys excellent<br \/>\nweblog.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Welcome to the first issue of HTB for 2010 which includes reports from the EACS Conference and updates of three important guidelines. At EACS, we start with a review that focused on the lack of screening programmes for anal cancer &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-7885","post","type-post","status-publish","format-standard","hentry","category-editorial"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/7885","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=7885"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/7885\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=7885"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=7885"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=7885"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}